| CAD millions | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | (0.1) | (0.1) | (0.0) | (0.0) | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.5 | 1.6 | 2.8 | 3.2 | 5.2 | 8.7 | +67.7% | |
| Selling & marketing | 0.4 | 0.1 | 0.4 | 0.5 | 3.6 | 6.1 | +66.9% | |
| Operating expenses | 1.5 | 1.6 | 3.0 | 3.4 | 5.2 | 8.7 | +67.7% | |
| Operating income | (1.5) | (1.6) | (2.8) | (3.0) | (5.2) | (8.7) | −67.7% | |
| Interest expense | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | +2531.0% | |
| Other income / expense | (3.0) | (0.0) | (0.1) | 1.8 | 2.1 | 2.5 | +19.9% | |
| Pre-tax income | (4.6) | (1.6) | (2.9) | (1.2) | (3.2) | (2.9) | +8.2% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | (0.2) | (1.8) | −867.3% | |
| Net income | (4.6) | (1.6) | (2.9) | (1.2) | (3.0) | (1.1) | +64.0% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.05) | (0.01) | (0.01) | (0.00) | (0.00) | (0.00) | +25.9% | |
| EPS, diluted (per share) | (0.05) | (0.01) | (0.01) | (0.00) | (0.01) | (0.00) | +63.6% | |
| EBITDA | (1.5) | (1.6) | (2.8) | (4.9) | (3.3) | (8.7) | −166.0% | |
| Depreciation & amortization | 0.9 | 0.1 | 0.0 | 0.0 | 1.9 | 0.0 | −100.0% | |
| Weighted average shares (shares) | 86,769,000 | 135,320,000 | 267,601,000 | 456,262,000 | 535,269,000 | 535,469,000 | +0.0% | |
| Weighted average diluted shares (shares) | 86,769,000 | 135,320,000 | 267,601,000 | 456,262,000 | 535,269,000 | 535,270,000 | +0.0% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in CAD; the shares trade in GBP.
